Xiaomo Li
Guangxi Medical University
18 Papers
1 Citations
Xiaomo Li is an academic researcher from Guangxi Medical University. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 3, co-authored 3 publications. Previous affiliations of Xiaomo Li include Northwestern University.
Chat about Author
Papers
Tailoring Nanostructure Morphology for Enhanced Targeting of Dendritic Cells in Atherosclerosis
Sijia Yi,Sean D. Allen,Yugang Liu,Brian Zhou Ouyang,Xiaomo Li,Punn Augsornworawat,Edward B. Thorp,Evan A. Scott +7 more
TL;DR: It is reported that nanostructure morphology alone can be engineered for selective uptake by dendritic cells (DCs), which are critical mediators of atherosclerotic inflammation and presented avenues for immunotherapies in cardiovascular disease.
106
Macrophage angiotensin-converting enzyme (ACE) reduces atherosclerosis by increasing PPARα and fundamentally changing lipid metabolism.
Duo-Yao Cao,Zakir Khan,Xiaomo Li,Suguru Saito,Ellen A. Bernstein,Aarón Víctor,Faizan Ahmed,Luciana C. Veiras,Mingtian Che,Lei Cai,Ryan E. Temel,Jorge F. Giani,Daniel Luthringer,Ajit S. Divakaruni,Derick Okwan-Duodu,Kenneth E. Bernstein +15 more
TL;DR: In this article , the role of macrophage angiotensin converting enzyme (ACE) in a mouse model of PCSK9 induced atherosclerosis was examined in a high fat diet.
21
Leishmaniasis and Chagas disease: Is there hope in nanotechnology to fight neglected tropical diseases?
Débora B. Scariot,Austeja Staneviciute,Jennifer P. Zhu,Xiaomo Li,Evan A. Scott,David M. Engman +5 more
TL;DR: Recent nanotechnological developments, the advantages of nanoformulations over current leishmanicidal and trypanocidal drugs, limitations of nano-based drugs, and research gaps that still must be filled to make these novel drug delivery systems a reality for leish maniasis and Chagas disease treatment are discussed.
Increased circulating T‑helper 22 cells in patients with dilated cardiomyopathy.
Qing Kong,Xiaomo Li,Weifeng Wu,Fan Yang,Yanli Liu,Wenyin Lai,Xiaofen Pan,Mengsha Gao,Yimin Xue +8 more
TL;DR: It is shown that patients with DCM, particularly those of the ANT autoantibody positive subjects, exhibit elevated levels of peripheral Th22 cells, indicating that a Th22 immune response may be implicated in the pathogenesis of DCM.
8
Case Report and Literature Review: Diagnosis, Tailored Genetic Counseling and Cancer Prevention for a Locally Advanced dMMR/MSI-H/TMB-H Lung Cancer Patient With Concurrent Lynch Syndrome Mediated by a Rare PMS2 Splicing Variant (c.1144+1G>A)
TL;DR: A locally advanced lung cancer patient with dMMR/MSI-H/TMB-H tumor and selective loss of PMS2 by immunohistochemistry was presented and the diagnosis of LS was made based on genetic analysis of this variant and literature review.